• 1 Swaroop Pandey , Anna Shteinfer-Kuzmine, Vered Chalifa-Caspi, and Varda Shoshan-Barmatz : Non-apoptotic activity of the mitochondrial protein SMAC/Diablo in lung cancer: Novel target to disrupt survival, inflammation, and immunosuppression. Frontiers in Oncology 2022, doi: 10.3389/fonc.2022.992260. Impact Factor 5.738 Q1
• 2 Swapnaja Gulawani, Pratibha Srivastava, Swaroop Pandey*, Reactive Oxygen Species in Cancer Management: Can Foe turns Friend? International Journal of Molecular Sciences (accepted). Impact Factor 5.6
• 3 Pandey SK, Machlof-Cohen R, Santhanam M, Shteinfer-Kuzmine A, Shoshan-Barmatz V: Silencing VDAC1 to Treat Mesothelioma Cancer: Tumor Reprograming and Altering Tumor Hallmarks. Biomolecules 2022, 12(7). Impact Factor 6.064 Q1
• 4 Pandey SK, Paul A, Shteinfer-Kuzmine A, Zalk R, Bunz U, Shoshan-Barmatz V: SMAC/Diablo controls proliferation of cancer cells by regulating phosphatidylethanolamine synthesis. Mol Oncol 2021, 15(11):3037- 3061. Impact Factor 7.441 Q1
• 5 Nunes JJ, Pandey SK (Equal First Author), Yadav A, Goel S, Ateeq B: Targeting NF-kappa B Signaling by Artesunate Restores Sensitivity of Castrate-Resistant Prostate Cancer Cells to Antiandrogens. Neoplasia 2017, 19(4):333-345. Impact Factor 6.214 Q1

All International Publications

• 1 Swaroop Kumar Pandey Uttpal Anand, Waseem A Siddiqui, Renu Tripathi. Drug development strategies for malaria: With the hope for new antimalarial drugs discovery- An update, (2023). Advances in Medicine, 2023:5060665. doi: 10.1155/2023/5060665. eCollection 2023.
• 2 Swaroop Kumar Pandey, Mradula, and Manikandan Santhanam. Aptamer-guided Selective Delivery of Therapeutics to Breast Cancer Cells Expressing Specific Biomarkers. Current Cancer Therapy Review (accepted). Impact factor 0.6
• 3 Almog Nadir, Anna Shteinfer-Kuzmine , Swaroop Kumar Pandey, Juan Ortas, Daniel Kerekes and Varda Shoshan-Barmatz, Pro-Apoptotic and Anti-Cancer Activity of the Vernonanthura Nudiflora Hydroethanolic Extract (2023), Cancers, - 15(5):1627. doi: 10.3390/cancers15051627. Impact factor 6.639.Q1
• 4 Ankit Verma, Anna Shteinfer-Kuzmine, Nicky, Avijit Paul, Edna, Vered Chalifa-Caspi, Swaroop Pandey, Alon Monsenago, Shira Knafo, Noga Vardi, and Varda Shoshan-Barmatz, (2023). Role of VDAC1 in Alzheimer’s disease. Translational Neurodegenration. 1(1):58, Impact Factor 9.883 Q1
• 5 Bhavana Singh Chauhan, Sarika Gunjan, Sunil Kumar Singh, Swaroop Kumar Pandey (Corresponding Author), Renu Tripathi. Future Pharmacology (2022), 2(4), 499-510.
• 6 Swaroop Pandey , Anna Shteinfer-Kuzmine, Vered Chalifa-Caspi, and Varda Shoshan-Barmatz : Non- apoptotic activity of the mitochondrial protein SMAC/Diablo in lung cancer: Novel target to disrupt survival, inflammation, and immunosuppression. Frontiers in Oncology 2022, doi: 10.3389/fonc.2022.992260. Impact Factor 5.738 Q1
• 7 Pandey SK, Machlof-Cohen R, Santhanam M, Shteinfer-Kuzmine A, Shoshan-Barmatz V: Silencing VDAC1 to Treat Mesothelioma Cancer: Tumor Reprograming and Altering Tumor Hallmarks. Biomolecules 2022, 12(7). Impact Factor 6.064 Q1
• 8 Pandey SK, Paul A, Shteinfer-Kuzmine A, Zalk R, Bunz U, Shoshan-Barmatz V: SMAC/Diablo controls proliferation of cancer cells by regulating phosphatidylethanolamine synthesis. Mol Oncol 2021, 15(11):3037- 3061. Impact Factor 7.441 Q1
• 9 Das T, Anand U, Pandey SK, Ashby CR, Jr., Assaraf YG, Chen ZS, Dey A: Therapeutic strategies to overcome taxane resistance in cancer. Drug Resist Updat 2021, 55:100754. Impact Factor 24.3 Q1
• 10 Dash SG, Kantevari S, Pandey SK, Naik PK: Synergistic interaction of N-3-Br-benzyl-noscapine and docetaxel abrogates oncogenic potential of breast cancer cells. Chem Biol Drug Des 2021, 98(3):466-479. Impact Factor 2.873 Q2
• 11 Agarwal AK, Singh AP, Gupta T, Agarwal RA, Sharma N, Pandey SK, Ateeq B: Toxicity of exhaust particulates and gaseous emissions from gasohol (ethanol blended gasoline)-fuelled spark ignition engines. Environ Sci Process Impacts 2020, 22(7):1540-1553. Impact Factor 5.334 Q1
• 12 Pittala S, Levy I, De S, Kumar Pandey S, Melnikov N, Hyman T, Shoshan-Barmatz V: The VDAC1- based R-Tf-D-LP4 Peptide as a Potential Treatment for Diabetes Mellitus. Cells 2020, 9(2). Impact Factor 7.666 Q1
• 13 Singh SK, Dwivedi H, Gunjan S, Chauhan BS, Pandey SK, Tripathi R: Potential role of arteether on N- methyl-D-aspartate (NMDA) receptor expression in experimental cerebral malaria mice and extension of their survival. Parasitology 2019, 146(12):1571-1577. Impact Factor 3.243 Q1
• 14 Agarwal AK, Singh AP, Gupta T, Agarwal RA, Sharma N, Rajput P, Pandey SK, Ateeq B: Mutagenicity and Cytotoxicity of Particulate Matter Emitted from Biodiesel-Fueled Engines. Environ Sci Technol 2018, 52(24):14496-14507. Impact Factor 11.357 Q1
• 15 Agarwal AK, Ateeq B, Gupta T, Singh AP, Pandey SK, Sharma N, Agarwal RA, Gupta NK, Sharma H, Jain A et al: Toxicity and mutagenicity of exhaust from compressed natural gas: Could this be a clean solution for megacities with mixed-traffic conditions? Environ Pollut 2018, 239:499-511. Impact Factor 9.988 Q1
• 16 Nunes JJ, Pandey SK (Equal First Author), Yadav A, Goel S, Ateeq B: Targeting NF-kappa B Signaling by Artesunate Restores Sensitivity of Castrate-Resistant Prostate Cancer Cells to Antiandrogens. Neoplasia 2017, 19(4):333-345. Impact Factor 6.214 Q1
• 17 Pandey SK, Biswas S, Gunjan S, Chauhan BS, Singh SK, Srivastava K, Singh S, Batra S, Tripathi R: Pyrrolidine-Acridine hybrid in Artemisinin-based combination: pharmacodynamics study. Parasitology 2016, 143(11):1421-1432. Impact Factor 3.243 Q1
• 18 Tiwari R, Pandey SK (Equal First Author), Goel S, Bhatia V, Shukla S, Jing X, Dhanasekaran SM, Ateeq B: SPINK1 promotes colorectal cancer progression by downregulating Metallothioneins expression. Oncogenesis 2015, 4:e162. Impact Factor 6.524 Q1
• 19 Ateeq B, Kunju LP, Carskadon SL, Pandey SK, Singh G, Pradeep I, Tandon V, Singhai A, Goel A, Amit S et al: Molecular profiling of ETS and non-ETS aberrations in prostate cancer patients from northern India. Prostate 2015, 75(10):1051-1062. Impact Factor 4.014 Q1
• 20 Gunjan S, Singh SK, Chauhan BS, Pandey SK, Ahmad H, Dwivedi AK, Tripathi R: Clarithromycin enhances the antimalarial efficacy of mefloquine via its increased bioavailability and disrupting P. falciparum apicoplast. Life Sci 2015, 136:126-132. Impact Factor 6.78 Q1
• 21 Pandey SK, Dwivedi H, Singh S, Siddiqui WA, Tripathi R: Antimalarial interaction of quinine and quinidine with clarithromycin. Parasitology 2013, 140(3):406-413. Impact Factor 3.243 Q1
• 22 Pandey SK, Mridul Mishra, Anindra Sharma, Hemlata Dwivedi, Pratiksha Singh, Praveen Kumar Shukla, Waseem Ahmad Siddiqui, Rama P Tripathi, Renu Tripathi (2012). Syntheses of low molecular weight hydroxamates as potent antiprotozoal and antifungal agents. Chemistry and Biology Interface, 2(6), 373-393.
• 23 Tripathi R, Rizvi A, Pandey SK, Dwivedi H, Saxena JK: Ketoconazole, a cytochrome P(450) inhibitor can potentiate the antimalarial action of alpha/beta arteether against MDR Plasmodium yoelii nigeriensis. Acta Trop 2013, 126(2):150-155. Impact Factor 3.222 Q2
• 24 Gahoi S, Jain GK, Tripathi R, Pandey SK, Anwar M, Warsi MH, Singhal M, Khar RK, Ahmad FJ: Enhanced antimalarial activity of lumefantrine nanopowder prepared by wet-milling DYNO MILL technique. Colloids Surf B Biointerfaces 2012, 95:16-22. Impact Factor 5.999 Q1
• 25 Fatima S, Sharma A, Saxena R, Tripathi R, Shukla SK, Pandey SK, Tripathi R, Tripathi RP: One pot efficient diversity oriented synthesis of polyfunctional styryl thiazolopyrimidines and their bio-evaluation as antimalarial and anti-HIV agents. Eur J Med Chem 2012, 55:195-204. Impact Factor 7.088 Q1
• 26 Tripathi R, Pandey SK, Rizvi A: Clarithromycin, a cytochrome P450 inhibitor, can reverse mefloquine resistance in Plasmodium yoelii nigeriensis- infected Swiss mice. Parasitology 2011, 138(9):1069-1076.Impact Factor 3.243 Q1
• 27 Ajay A, Singh V, Singh S, Pandey S, Gunjan S, Dubey D, Sinha SK, Singh BN, Chaturvedi V, Tripathi R et al: Synthesis and bio-evaluation of alkylaminoaryl phenyl cyclopropyl methanones as antitubercular and antimalarial agents. Bioorg Med Chem 2010, 18(23):8289-8301. Impact Factor 3.461 Q2
• 28 Misra M, Pandey SK, Pandey VP, Pandey J, Tripathi R, Tripathi RP: Organocatalyzed highly atom economic one pot synthesis of tetrahydropyridines as antimalarials. Bioorg Med Chem 2009, 17(2):625-633. Impact Factor 3.461 Q2
• 29 Madapa S, Tusi Z, Mishra A, Srivastava K, Pandey SK, Tripathi R, Puri SK, Batra S: Search for new pharmacophores for antimalarial activity. Part II: synthesis and antimalarial activity of new 6-ureido-4- anilinoquinazolines. Bioorg Med Chem 2009, 17(1):222-234. Impact Factor 3.461 Q2.

Presentation in Conference/Symposia

• 30 Komal Singh, Rucha Chadwaskar, Saurabh Gupta, Swaroop Kumar Pandey and Jagdip Singh Sohal. Role of ϒδT cells in the etiology of IBD. Sustanable and Innovative Solutions for India @75. Held at IMS, Gaziabad on 12-13th May 2023.
• 31 Mukta Jain, Rasanpreet Kaur, Pragya Prasanna, Saurabh Gupta, Umesh Kumar, Swaroop Kumar Pandey and Jagdip Singh Sohal. Optimization of Recombinanat Soluble Production of ‘VP7’ Protein and Immuno-Proteomic Analysis. Sustanable and Innovative Solutions for India @75. Held at IMS, Gaziabad on 12-13th May 2023.
• 32 Maya Datt Joshi, Shoorvir Singh, jagdip Singh Sohal and Swaroop Kumar Pandey. Cannabis species Potential Source of Anticance Agents. Sustanable and Innovative Solutions for India @75. Held at IMS, Gaziabad on 12-13th May 2023.
• 33 V. Shoshan¬Barmatz , T. Arif I , S. Pandey, A. Paul, The metabolic cross­talk between mitochondria and the nucleus and its function in cancer. March 2022.
• 34 Pandey SK, Paul A, Shoshan-Barmatz V. SMAC/Diablo new function in regulation of phospholipids synthesis in cancer cells via modulation of the mitochondrial phosphatidylserine decarboxylase activity. The 6th Biannual Meeting on Mitochondria, Apoptosis & Cancer, took place in Prague, Czech Republic 2019.
• 35 Swaroop KumarPandey, Amber Rizvi and Renu Tripathi .“Possible Alternatives of human serum for continuous culture of Plasmodium falciparum” In 19th National Congress of Parasitology and International Symposium on Parasitic Diseases of Animals and Man at Department of Zoology, Andhra University, Visakhapatnam (India), October 26–28, 2007.
• 36 Amber Rizvi,J.K.Saxena, Swaroop Kumar Pandey and Renu Tripathi “Involvement of Cytochrome P450 enzyme in anti-malarial drug resistance”. In 19th National Congress of Parasitology and International Symposium on Parasitic Diseases of Animals and Man at Department of Zoology, Andhra University, Visakhapatnam (India), October 26–28, 2007.
• 37 Amber Rizvi Swaroop K. Pandey, J.K. Saxena, Sarika Gunjan and Renu Tripathi. “Biochemical Mechanism of drug resistance in rodent malaria”. In 20th National Congress of Parasitology at Department of Zoology, North Eastern Hill University, Shiliong (India), november 3–5, 2008.
• 38 Swaroop K. Pandey, Mridul Mishra, R.P. Tripathi, Amber Rizvi, Sarika Gunjan and Renu Tripathi. “Hydroxamates: As broad spectrum Anti-protozoals”. In 20th National Congress of Parasitology at Department of Zoology, North Eastern Hill University, Shiliong (India), November-3–5, 2008.
• 39 Hemlata Dwivedi, Swaroop Kumar Pandey, Amber Rizvi and Renu Tripathi. “Actenomycetes extracts: A potent Antitrypanosomal agent.” In 21st National Congress of Parasitology at Department of Zoology, Punjab University, Chandigarh (India), november 14–16, 2009.
• 40 Sarika Gunjan, Swaroop Kumar Pandey and Renu Tripathi. “Role of folate in RPMI medium and its effect on DHFR inhibitors.” In 21st National Congress of Parasitology at Department of Zoology, Punjab University, Chandigarh (India), november 14–16, 2009.
• 41 Swaroop K. Pandey, Mridul Mishra, R.P. Tripathi and Renu Tripathi. “Antimalarial activity of newly synthesized fernesyltransferase inhibitors”. In 20th all India Congress of Zoology at CIFE Versoa Mumbai, Dec. 29-31,2009.
• 42 Mridul Mishra, S. K. Pandey, Renu Tripathi and R.P. Tripathi. “Organocatalysed one pot synthesis of polyfunctional tetrahydropyridine and their antimalarial evaluation”. In National conference on recent trends in organic synthesis, at Bharathidasan University, Tamilnadu. 24-26 February 2011.
• 43 Swaroop Kumar Pandey, Arya Ajay, R.P. Tripathi and Renu Tripathi. Antimalarial potential of aryl cyclopropyl methanones. In national seminar on Challenges in drug discovery and development 9-10 December 2011 at CDRI Lucknow.
• 44 Swaroop Kumar Pandey, Sarika Gunjan, Hemlata Dwivedi and Renu Tripathi. Antibiotic-based combination (ABC): Choice of treatment for malaria. In 22nd All India Congress of Zoology. Held at Lucknow University on 29-31 December 2011.

Book Chapter

• 45 Renu Tripathi, Sangeeta Dhavan, Aseem Umesh, Swaroop K Pandey and G.P.Dutta.”Status of Drug Resistant Malaria and Current Strategy for its Control” World of Pests and Parasites 2009, pp 1-37.